milestones
Founded 2004
Partnered 2021
Acquired (Vertex) 2022
Team
Michael Yang
Board
LEAD INVESTOR
category
Cardiopulmonary + Metabolic
Immunology
Regenerative medicine company focused on delivering novel stem cell-derived cell replacement therapies as a functional cure for all type 1 diabetes and a next-generation treatment for insulin-requiring type 2 diabetes
No items found.
